PICMA Supply Chain Management’s Post

Health for all! Everyone, everywhere, has the right to good health. As innovators, we develop and support solutions that provide quality health services, education and information to all. 💙 This #WorldHealthDay, we’re highlighting our sprint innovations from the first edition of the Kofi Annan Award for Innovation in Africa, which focused on bringing #SDG3 solutions to greater heights in the midst of the COVID-19 pandemic. We had a special focus on Indicator 8, which gives the most vulnerable and inaccessible access to quality essential healthcare services and safe, effective, quality and affordable essential medicines and vaccines. Learn more about myPaddi, VaxiGlobal and @Flare below 🚀 Austrian Federal Chancellery Austrian Development Agency Kofi Annan Foundation #KAIAA #ZeroHunger #DisruptHunger

📣It was a great pleasure for Phase4AI-EUProject project to participate today in an online meeting organized by the European Health and Digital Executive Agency (HaDEA), which oversees the implementation of the Horizon Europe Health Cluster, as well as other EU programmes. 📝The agenda consisted of an introduction to HaDEA and to principles for good collaboration between projects and the Agency, followed by a presentation by the European Medicines Agency (EMA). Parallel break out meetings were organized for each topic after the plenary session. #healthcare, #machine_learning, #data_analytics, #data_protection, #synthetic_data, #multiparty_computation

🌍 Swissmedic attaches great importance to development cooperation. In a discussion with Swissmedic's media spokesperson Alex Josty, Lodovico Samuele Paganini explains how we can improve access to therapeutic products in poorer countries through international cooperation and training with the World Health Organization (WHO). As chair of the technical partners in the African Medicines Regulatory Harmonization Programme (AMRH), we are actively committed to faster authorisation processes to make vital medicines available more efficiently. 🤝 With our partnerships we aim to improve global healthcare and achieve lasting progress together with other organisations such as the WHO and the Bill & Melinda Gates Foundation. 🚀 Find out more in the Visible article “Pioneering work for Africa” 🔗📰 https://bit.ly/3W2qxyR #developmentcooperation #Swissmedic #healthcare

🌍 💊 The European Health Management Association (EHMA) is proud to be a part of the #CriticalMedicinesAlliance (CMA). Established in January 2024, the #CMA unites stakeholders from EU Member States, key industries, civil society, and the scientific community to enhance the supply of critical medicines within the EU. The alliance aims to prevent and address medicine shortages, ensuring timely and equitable access to medicines for all European patients in line with the goals of the European Health Union.   As a part of the Alliance, EHMA advocate for the Health Emergency Preparedness and Response Authority (HERA) to prioritise the digitalisation and automation of medication management systems in EU hospitals. Real-time stock visibility is essential for the Critical Medicines Act, and EHMA supports a Medicines Alliance's project aiming for 90% digitalisation in EU hospitals by 2026, aligned with the #EU4Health program.   EHMA also emphasises the importance of sharing best practices from regions or hospitals that have successfully invested in digitalisation to enhance medicine stock and demand data across the EU.   ➡ Learn more about the Alliance: https://lnkd.in/ejCraq7K 📑 Read EHMA’s recommendations for hospitals' medication management pathways in our latest position paper: https://lnkd.in/ejCraq7K   Together, we are committed to a future where all European patients have reliable access to the critical medicines they need.   #HealthcareInnovation #EHMA #CriticalMedicinesAlliance #EUHealth #DigitalHealthcare #Pharmaceuticals #HealthManagement #EU4Health Laurent Muschel Stella Karavazaki Wolfgang Philipp Daphne Von Buxhoeveden Cornelius Schmaltz Olivier Girard Anne Simon European Alliance for Access to Safe Medicines

The new EU Health Technology Assessment regulation (HTAR) holds great promise for patients in the EU, aiming to achieve faster access to innovative medicines in the long term. However, its success depends on all the stakeholders in the ecosystem – including PharmaCos. In our recent conversations with PharmaCos of different size, we discussed various approaches that companies are already undertaking to prepare for the HTAR implementation.   In collaboration with my Strategy& and @PwC colleagues Dr. Thomas Solbach, Iryna (Stadnyk) Scheurlen, Burcu Yetkin, Khushbu Lalwani Goulden, Sebastian Schwärzler, João Aguiar Machado, Elina Osoianu, Lukas Rabl, and Armaan Bajaj, we outline key future implementation enablers to further support the successful implementation of the new regulation, including leveraging and benefitting from the latest technology. Find out more here: https://lnkd.in/ekcD8Dwv

Saudi Arabia’s Minister of Health Fahad AlJalajel recently met with officials in Greece to explore opportunities for enhanced collaboration in healthcare. From exchanging best practices to opening doors for medical research and innovation, this visit signals a major step toward stronger international healthcare partnerships. https://lnkd.in/dGP6za9F

Burjeel Holdings and Asandha have joined hands to bring world-class healthcare to the people of the Maldives here in Abu Dhabi. This partnership highlights Abu Dhabi's growing role as a global hub for medical tourism, ensuring advanced care is within reach for all. Prof.Humaid Al-Shamsi MB(IRL),FRCP(Lon),FRCP(Ca),FRCP(Glasgow),FACP(US) Burjeel Holdings #MedicalTourism #BurjeelHoldings #AbuDhabi #Maldives

📢Swissmedic receives grant from the Bill & Melinda Gates Foundation ✍️On 27 March 2024, Swissmedic signed a new grant agreement with the Bill & Melinda Gates Foundation. Under the terms of this agreement, both parties commit to supporting regulatory authorities in low and middle-income countries for a further three years, thereby improving access to healthcare in the targeted regions and countries. 🌐💊This commitment is aligned with Swiss health foreign policy and contributes to the implementation of its priority action area “Access to medicine”. https://bit.ly/3W0qyon

🗨 𝗧𝗲𝘀𝘁𝗶𝗺𝗼𝗻𝗶𝗮𝗹 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 The EU-X-CT initiative is driven by dedicated volunteers representing all stakeholder categories - from patients to regulatory experts from all over Europe. Read below to see what motivated our members to join! 💪 #EUXCT #ClinicalTrials #HealthcareInnovation #EUHealthcare #CrossBorderTrials #RareDiseases

The Clinical Research and Trials Community (CRTC) programme is dedicated to creating a sustainable #clinicaltrials ecosystem in #Africa. With over 20 stakeholders engaged across our three initiatives, we focus on increasing investments in ethical trials, fostering trust among our stakeholders, and building research capacity. As we commemorate #ICTD2024, we celebrate our progress and reaffirm our commitment to improving healthcare across the continent. read more 👉 : https://bit.ly/44QtdmV #ClinicalTrialsDay #HealthcareInnovation #Sustainability. nuvoteQ.io European Union Johnson & Johnson Medicines Development for Global Health BVGH Seattle Global Health EDCTP3 Fondation Mérieux